Medtronic (MDT-NYSE) posted quarterly results with revenues up 75 to $3.28 Billion, helped on currency by $71 million. Net earnings were 4812 million, or $0.70 EPS but $0.66 adjusting for charges and tax benefits. First Call estimates were $0.62 EPS and $3.27 Billion revenues. Shares closed up 0.45% ahead of earnings in normal trading and shares are up another 1.8% at $51.75 in after-hours trading. Unfortunately we have no guidance out of the company in this release, so this one is still an "outstanding and unresolved issue" until that is known.
MDT’s 52-week trading range is $42.37 to $54.86.
Jon C. Ogg May 22, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.
If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.
